Dilapan-S/Dilasoft E-Registry in Induction of Labor

Completed

Conditions studied: Labour Onset and Length Abnormalities, Labor; Forced or Induced, Affecting Fetus or Newborn

In brief

International Observational E-Registry on the use of DILAPAN-S® osmotic dilator / DILASOFT® osmotic dilator for cervical ripening prior to labour induction.

Key facts

Study ID

NCT02318173

Run by

Medicem International CR s.r.o.

People needed

444

Starts

2015-05-01

Expected to finish

2016-12-01

Last updated by the study team

2017-05-19

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Indication for induction of labor
• Unfavourable cervix

You may not qualify if…

• Presence of overt genital tract infection

Where it is running

• Bellevue Hospital — New York, New York, United States
• University of Texas Medical Branch Galveston — Galveston, Texas, United States
• Masaryk University — Brno, Czechia
• Vivantes Klinikum im Friedrichshain — Berlin, Germany
• Buerger Hospital — Frankfurt am Main, Germany
• Guru Teg Bahadur Hospital — New Delhi, National Capital Territory of Delhi, India
• Sri Ramachandra Medical Center — Chennai, Tamil Nadu, India
• Fernandez Hospital — Hyderabad, Telangana, India
• Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology" of the Ministry of Healthcare of Russian Federation — Moscow, Russia
• University Hospital Trnava — Trnava, Slovakia
• Birmingham Women´s Hospital — Birmingham, West Midlands, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.